[Disorders of calcium phosphate homeostasis in patients with intermittent hemodialysis therapy].
D000141:Acidosis, Renal Tubular / Q000378:metabolism; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D002128:Calcium Metabolism Disorders / Q000188:drug therapy; D002130:Calcium Phosphates / Q000378:metabolism*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000378:metabolism; D007408:Intestinal Absorption; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000628:therapy; D006435:Renal Dialysis; D014807:Vitamin D / Q000627:therapeutic use
D002130:Calcium Phosphates; D014807:Vitamin D; D000536:Aluminum Hydroxide
Störungen der Kalzium-Phosphathomöostase bei Patienten unter intermittierender Hämodialysebehandlung.